NEW LIFE MEDICINE TECH COMPANY LIMITED has a total of 14 patent applications. It decreased the IP activity by 28.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, Taiwan and China. Its main competitors in its focus markets organic fine chemistry, measurement and biotechnology are CISBIO BIOASSAYS, CELL2IN INC and ECHELON BIOSCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Taiwan | 3 | |
#3 | China | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Measurement | |
#3 | Biotechnology | |
#4 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Special acyclic compounds | |
#3 | Heterocyclic compounds | |
#4 | Measuring microorganism processes | |
#5 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Wong Ka Leung | 12 |
#2 | Chan Chi Fai | 5 |
#3 | Lan Rongfeng | 5 |
#4 | Li Hongguang | 5 |
#5 | Wong Ka-Wing | 2 |
#6 | Kan Chun Wai | 2 |
#7 | Tsoi Tik Hung | 2 |
Publication | Filing date | Title |
---|---|---|
US2020355691A1 | Direct Colorimetric Detection of Spermine using Gold Nanoparticles | |
US2019127393A1 | Lanthanide toolbox for organelle specific molecular imaging with multi-color | |
CN111201224A | Uropolyamines as biomarkers for prostate cancer detection | |
US2018252652A1 | Urinary polyamines as prostate cancer detection biomarkers | |
US2018172695A1 | Urinary polyamines as prostate cancer detection biomarkers | |
US2017342090A1 | Lanthanide toolbox for organelle specific molecular imaging |